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Abstract 
We present a high content multiwell plate cell-based assay approach to quantify protein interactions 
directly in cells using Förster resonance energy transfer (FRET) read out by automated fluorescence 
lifetime imaging (FLIM). Automated FLIM is implemented using wide-field time-gated detection, 
typically requiring only 10 s per field of view (FOV). Averaging over biological, thermal and shot noise 
with 100’s to 1000’s of FOV enables unbiased quantitative analysis with high statistical power. 
Plotting average donor lifetime vs. acceptor/donor intensity ratio clearly identifies protein 
interactions and fitting to double exponential donor decay models provides estimates of interacting 
population fractions that, with calibrated donor and acceptor fluorescence intensities, can yield 
dissociation constants. We demonstrate the application to identify binding partners of MST1 kinase 
and estimate interaction strength among the members of the RASSF protein family, which have 
important roles in apoptosis via the Hippo signalling pathway. KD values broadly agree with 
published biochemical measurements.  
 
 
With increasing knowledge of intracellular signalling networks, it becomes more evident that 
molecules can be involved in processes occurring in multiple pathways. Understanding the complex 
interconnections between different pathways requires comprehensive identification of specific 
binding partners, and therefore it is important to develop higher throughput techniques to search 
for new interactions. Currently, biochemical methods are most often used to this end and provide 
high sensitivity. However, they require long separation procedures, during which the active 
molecules are isolated from their native environment, and may present different reaction kinetics 
than in live cells where molecular crowding and high compartmentalisation could have an impact. 
Fluorescence microscopy – particularly exploiting genetically expressed fluorescent proteins – can be 
applied directly to map and quantify protein interactions in live or fixed cells and preserve 
information concerning the inhomogeneous cellular distribution of molecules, with typical spatial 
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resolution below 0.5 μm. With the advent of superresolution microscopy, the prospect of sub-50 nm 
resolution could permit the study of the organisation and dynamics of molecules within organelles 
and large interacting complexes1,2. However, manual fluorescence microscopy experiments are 
subject to operator bias and it is impractical to undertake measurements on a sufficient number of 
cells to identify systematic errors and to average over “biological noise”. Large scale screening using 
automated fluorescence microscopes can provide higher throughput studies of signalling processes 
with improved statistical significance. To date, high content analysis platforms for cell imaging have 
been mostly based on fluorescence intensity readouts and have predominantly been applied to 
study the effects of inhibitors on signalling pathways3. Other fluorescence parameters may also be 
utilised to assay molecular environment (fluorescence lifetime) or fluorophore orientation 
(polarisation/anisotropy). 
A widely used fluorescence technique to study bi-molecular interactions within cells is FRET (Förster 
resonant energy transfer), which utilises the non-radiative (dipole-dipole) energy transfer from a 
fluorescent donor to an acceptor that can take place only when the two fluorophores are situated at 
distances <10 nm. In the case of two proteins labelled with donor and acceptor tags, this implies that 
FRET occurs only if and when the two proteins interact with each other. FRET has therefore been 
widely exploited to study protein interactions using fluorescence microscopes. However, its 
application for high content analysis in automated multiwell plate readers is much more limited. 
FRET can be read out using a wide range of techniques4 although most of these are not practical for 
rapid automated assays of multiwell plates where hundreds to thousands of fields of view must be 
imaged in a single experiment. 
One approach to detect FRET is to measure the fluorescence intensity ratio of the acceptor and the 
donor, observing the increase of the fluorescence intensity in the acceptor channel with the 
simultaneous decrease of the intensity in the donor channel. This spectral ratiometric imaging 
acquisition is fast, but requires additional control samples to correct for spectral cross-talk between 
the fluorophores and to calibrate the spectral response of the specific optical set-up (instrument and 
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sample corrections), making comparison between different samples difficult. Quantitation can be 
degraded by unknown variations in donor-acceptor stoichiometry and quantitative readouts of FRET 
efficiency and population fraction of FRETing donors are not possible without additional 
measurements of reference FRET constructs5,6. 
It is also possible to utilise the depolarisation of the acceptor fluorescence as a FRET readout since 
donors excited with polarised light transfer energy to acceptors with a wider range of dipole 
orientations. Polarisation-based measurements can achieve similar acquisition speeds as spectral 
ratiometric readouts and are highly sensitive to detect the occurrence of FRET, but it is again difficult 
to quantify FRET efficiencies and population fractions of interacting donors7,8. Polarisation has been 
applied as a first step to screen for possible interaction partners that were subsequently investigated 
using fluorescence lifetime9. 
Fluorescence lifetime imaging (FLIM)10 provides a more robust approach to reading out FRET since 
only measurements of the donor fluorophores are required – negating the need for control samples 
or spectral calibration and providing readouts that can be directly compared between instruments 
and which can be translated from cell-based assays to animal models11. Compared to spectral or 
polarisation ratiometric techniques, FLIM requires more detected photons to achieve a given 
accuracy, so this is a slower modality for mapping and quantifying FRET in high content analysis. 
However, FLIM can also provide more quantitative readouts in a single spectral channel since the 
fluorescence decay profiles can be fitted to complex models in order to obtain the FRET efficiency 
and the interacting population fraction. Time-resolved measurements can be extended to analyse 
homoFRET and polarisation anisotropy decays using appropriate models. Fitting lifetime data to 
complex models typically requires 10,000’s of photons – compared to ∼200 photons required to fit 
to a monoexponential decay model12 – and it is not possible to detect such high photon numbers per 
pixel from biological samples such as cells labelled with fluorescent proteins before photobleaching 
and phototoxicity ensue. However, global analysis techniques that fit data simultaneously from 
many pixels can overcome this limitation (subject to assumptions about spatial invariance of lifetime 
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components across the data set) and enable FLIM data with only 100’s photons/pixel (i.e. 
compatible with live cell imaging) to be fitted to complex decay models. Quantitative information 
can also be directly obtained without fitting using the phasor analysis approach13,14. 
In this paper we report the application of a prototype high content assay platform providing 
unsupervised FLIM FRET of multiwell plate arrays that can identify protein binding partners in their 
cellular context and quantify the dissociation constant, KD. In order to achieve the fast FLIM 
acquisition required for reading 96-well plates, we utilise wide-field time-gated imaging to realise a 
FLIM microscope that is able to automatically acquire wide-field or optically sectioned fluorescence 
lifetime images with a typical mean acquisition time of 10 seconds per field of view for cells 
expressing fluorescent proteins, including the time required to move from the previous field of view 
and to automatically focus the microscope. For the first time to our knowledge, we report the 
application of automated FLIM FRET to screen for protein binding partners within cells – here shown 
to identify interactions between the Ras-association domain family (RASSF) and mammalian sterile 
20-like kinases (MST) – and the estimation of the KD for these interactions. 
The RASSF family consists of ten members, RASSF1-10, which share a common Ras association 
domain. The role of this domain is not yet fully understood15, but the RASSF proteins are 
components of the MST/Hippo pathway which is considered to restrict cell proliferation, thus 
playing potentially important roles in suppressing tumourigenesis16-22. This could oppose the 
Raf/Mek/Erk stimulation of cell growth/proliferation also dependent on Ras activation (figure 1). 
More recently, RASSF1 and MST1 have also been shown to influence the cardiac function in 
response to stress23, whilst RASSF5 and MST1 are involved in mediating TNFα- and TRAIL-induced 
apoptosis24. 
The C-terminal domains differ between the classical RASSF1-6 and the N-terminal RASSF7-10. The 
classical RASSF members have a common α-helical SARAH domain that is absent in the N-terminal 
RASSF members, which instead are predicted to have coiled-coil motifs at various positions towards 
their C-terminal region25. The SARAH domain, whose name is essentially derived from the three 
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proteins that share this common feature at their extreme C-terminal region: Salvador/RASSF/Hippo16 
is also found in the MST kinases. The mammalian homologues, WW45, RASSF and MST respectively, 
are components of the well conserved Hippo signalling pathway, which was first described in 
Drosophila melanogaster. 
Recent studies have shown that the SARAH domain is able to dimerise in solution26-28, so it was 
hypothesized that dimerisation could represent a key mechanism of interaction between the MST 
kinases and RASSF proteins. It is thought that, through this dimerisation, RASSFs are involved in the 
regulation of the catalytic activity of MST kinases (figure 1). Being themselves devoid of enzymatic 
activity, RASSF proteins may act as scaffolds binding the MST kinases. Previous studies have shown 
interaction between several RASSF members and different Ras proteins15,29-31, leading to the 
hypothesis that Ras association localizes RASSFs and the MST kinases to the cell membrane, thus 
bringing the MST kinase domains into close proximity for trans-activating phosphorylation, driving 
the MST/Hippo pathway and cellular apoptosis17,18,32. 
The SARAH dimer is formed via a head-to-tail interaction of the two helices in an antiparallel 
arrangement. Although different coiled-coil motifs have been described to form oligomers33,34, there 
is no evidence thus far to suggest that the predicted coiled-coils in the N-terminal RASSF7-10 are 
capable of associating with the SARAH domain of MST to promote their interactions. This study 
aimed to confirm at the cellular level that SARAH-mediated dimerisation is the mode of interaction 
by identifying the RASSF proteins that associate with MST1 kinase or its isolated SARAH domain. In 
addition, point mutations were also introduced within the SARAH domains of the more well-studied 
members, RASSF1 and 5, to study their effect on the dimerisation with the MST1-SARAH domain, 
which were assayed using FRET. 
 
Results and discussions 
Figure 2 illustrates the fluorescent constructs that have been created to assay the RASSF-MST 
interactions using FRET. All ten RASSF proteins have been modified by attaching the fluorescent 
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protein EGFP to their N-terminus to serve as a donor. Similarly, the MST1 kinase and its isolated 
SARAH domain (SARAHMST1) were labelled with mCherry at the N-terminus to provide the acceptor 
for the FRET assays. To evaluate the effect of possible non-specific interactions on the FRET readouts 
(e.g. arising from high local concentration of donor and acceptor), two negative controls were 
employed: the free fluorescent protein mCherry was expressed (without being linked to the MST1 or 
SARAHMST1 domain) and, as a more biologically relevant control, the kinase domain of the MST1 with 
a deletion of the SARAH domain (MST1ΔSARAH) was tagged with mCherry at its N-terminus. 
Figure 3 shows a diagram of the automated FLIM multiwell plate microscope that can be configured 
for wide-field imaging or for optical sectioning using a Nipkow spinning disk unit, the latter providing 
more quantitative readouts at the cost of increased complexity. FLIM is realised using a gated optical 
intensifier that acts as a fast (∼100 ps rise time) electronic shutter synchronised with the laser 
pulses, opening at various delays after excitation to provide time-gated fluorescence intensity 
images for each time delay, integrated over a few seconds. From these images, the fluorescence 
decay profiles can be reconstructed and analysed by fitting to an appropriate exponential decay 
model. 
To obtain reliable statistics, we automatically acquired FLIM images from 10 fields of view (FOV) per 
well, using 5 time gates to sample the fluorescence decay profiles with exposure times around 1 s 
per gate for the donor (EGFP) images. Intensity images of the acceptor (mCherry) were also obtained 
with direct excitation for the same fields of view. Approximately 800 FLIM images were thus 
acquired for each multiwell plate. Such large FRET data volumes require rapid automated analysis, 
for which we have developed an open source program called FLIMfit35 (available at 
http://www.openmicroscopy.org/site/products/partner/flimfit), based on the variable projection 
method and providing tools for segmentation of cells containing both donor and acceptor, 
monoexponential and global analysis of EGFP lifetime using convolution and background correction, 
as well as analysis of fluorescence intensity images.  
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For these assays, COS7 cells were transfected with donor only plasmids (EGFP-RASSF) and two 
different conditions of donor plus acceptor constructs: (i) EGFP-RASSF + mCherry-SARAHMST1 
(interaction partner) and (ii) EGFP-RASSF + mCherry-MST1∆SARAH as the negative control (figure 
4A). Figure 4 shows the results of this screen, displaying the mean donor lifetime fitted to a 
monoexponential decay profile and averaged across 10 FOV per well. Although we expect to identify 
two EGFP lifetime components corresponding to free and SARAH-bound RASSF in co-transfected 
cells, here we show that a monoexponential fit (equation 1) provides a convenient average lifetime 
value (τ) per cell that can be used for qualitative readouts of the occurrence or absence of the 
protein-protein interaction. 
𝐼𝐼(𝑡𝑡) = 𝐼𝐼0𝑒𝑒−𝑡𝑡/τ           Eq. 1 
The average EGFP donor lifetimes calculated from the monoexponential pixel-wise fit of all FOV in 
each of the 96 wells of the RASSF-SARAH plate are displayed as a colour coded plate map (figure 4A). 
Box plots of lifetimes calculated per cell per condition are also shown (figure 4C). A montage of FLIM 
images showing one FOV per well is presented in figure 4B. 
When cells co-transfected with the negative control (mCherry-MST1∆SARAH) are compared with 
those transfected with the donor only, the average of the mean lifetime differences for each RASSF 
family member was 6±8 ps, with a maximum change in mean fluorescence lifetime of 16 ps for 
RASSF3. These results represent the biological noise in our measurement. Therefore, to be 
conservative, we considered that a lifetime shift of at least 32 ps – i.e. twice the maximum 
difference observed between donor only and donor plus negative control – should be required for it 
to be considered significant.  
In the case of RASSF and SARAHMST1 co-transfection, the average EGFP lifetime is reduced by 130-
310 ps for RASSF1-6 (table S.3, supplementary information). This reduction is above our threshold 
for significance, as outlined above. For RASSF7-10, the reduction of the mean EGFP lifetime in cells 
co-transfected with SARAHMST1 was less than 32 ps, suggesting little or no donor-acceptor interaction 
(table S.3, supplementary information). 
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The donor and acceptor-labelled proteins used in these experiments were encoded using separate 
plasmids and therefore they will not be expressed in a 1:1 ratio in the cells (figure 4D). Variations in 
the donor/acceptor ratio do impact the magnitude of the FRET readout and could also impair the 
significance of the negative controls. For example, if more acceptor molecules are expressed in one 
cell compared to another, more donor molecules may be quenched and the average donor 
fluorescence lifetime per cell would then be shorter. In order to clarify this issue, 2D plots of EGFP 
donor lifetimes versus acceptor/donor intensity ratios have been constructed after segmenting 
individual cells in all FOVs (figure 4E). While a finite spread of the EGFP lifetimes is observed for each 
condition, the EGFP lifetime distributions for RASSF1-6/SARAHMST1 co-transfection only have a small 
overlap with the distribution of the negative control, the average lifetime being reduced even at low 
acceptor concentration, as would be expected for FRET. For RASSF7-10/SARAHMST1 co-transfection, 
the EGFP lifetime distributions are centred on similar values as for the negative control, even for 
high acceptor/donor ratios, indicating a lack of FRET and therefore a weak or no interaction. These 
2D plots support the qualitative readouts provided by the average EGFP lifetime obtained from the 
monoexponential fit of intensity decays that are seen to be robust in the presence of variation in the 
donor/acceptor stoichiometry. Overall, these results indicate the specific interaction based on the 
dimerisation of the SARAH domains between RASSF1-6 and MST1, while there is very little or no 
interaction between the SARAH domain and the coiled-coil or unstructured regions at the C-terminal 
end of RASSF7-10. 
The results of this intracellular FRET assay are supported by biochemical data15 and by the SARAH 
domain heterodimer structural models (depicted in figure S.1 in the supplementary information) 
showing that most of the main interacting residues of all six SARAHRASSF monomers are well-
conserved and aligned to heterodimerise with the SARAHMST1 monomer. The contact interface 
mainly involves the side chains and non-polar residues for all six heterodimers, with a small degree 
of polar or charged interaction between the acidic and basic residues (see also table S.1 in the 
supplementary information). 
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Based on these structural models, we selected three key non-polar residues in the main helix for 
further mutational studies. These are residues that align to L444, L448 and L451 in SARAHMST1 and 
they are highly conserved, as well as major contributors to dimer formation and stability. We applied 
our FRET screening technique to study the effect of three point mutations within the SARAH 
domains of RASSF1 and RASSF5C, which are the two best characterised RASSF members with 
published literature on their L308P and L224A mutants respectively23,36. All mutations involved the 
replacement of leucine residues with proline at the positions described above. We chose to perform 
these mutations since proline residues have been shown to introduce distortions (kinks) to α-
helices37, in our case in the main helix facilitating the dimerisation with the SARAHMST1 domain26,28.  
Figures 5 and 6 show the results of FRET assays of interaction between the wild type isolated 
SARAHMST1 domain and the point mutated RASSF1 and RASSF5 constructs. The average EGFP 
lifetimes obtained by fitting to a monoexponential decay model indicate that all three point 
mutations introduced within the SARAH domain of RASSF1 inhibit dimerisation with the isolated 
SARAHMST1 domain (figure 5A). The box plots in figure 5B indicate that the average values of the 
EGFP lifetimes show differences of less than 17 ps when co-expressed with the MST1∆SARAH 
domain or with mCherry alone as negative controls. The distributions of the EGFP lifetimes versus 
the acceptor/donor intensity ratios of all RASSF1 mutants overlap with those of the negative control 
for all acceptor expression levels (figure 5D). 
In the case of the three RASSF5C mutants, we observe a reduction in the average EGFP lifetimes 
compared to the negative control based on the box plots in figure 6B, suggesting that dimerisation 
of the SARAH domains still occurs. The distributions on the 2D plots in figure 6D are clearly different 
for the mCherry-SARAHMST1 domain co-transfection compared to the co-transfection with mCherry 
(negative control). However, the reduction in mean EGFP lifetime in individual cells expressing the 
mutants is smaller than that observed with the wild type RASSF5C, suggesting that the fraction of 
the bound molecules is reduced in the case of RASSF5C mutants compared to the wild-type protein, 
which could be due to a reduction in binding affinity. 
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These FRET screening data are also supported by biochemical assays, represented in figures 7 and 8, 
where full length proteins were used to better mimic physiological conditions. For RASSF1 (figure 7), 
only the wild-type protein showed strong binding to MST1, whereas the signals from the mutants 
were significantly weaker. In the case of RASSF5 (figure 8), the mutants were still detected at a 
significant level, but reduced compared to the wild-type protein. In agreement with the FRET data, 
these biochemical assays indicate that, while binding still occurs, the affinities are reduced by the 
mutations. 
The different degrees of disruption to heterodimerisation caused by the SARAH mutations in RASSF1 
and RASSF5 observed both in our FRET and biochemical data (figures 5-8) could be due to distinct 
biochemical and structural properties of the individual SARAH domains, such as local variations in 
the specific residues involved in the individual heterodimeric interfaces or in the residues 
surrounding the mutated sites. It is possible that the neighbouring residues could compensate for 
the effects of the mutation in RASSF5, but not in RASSF1. Similarly, the leucine residues and 
hydrophobic interactions may play a more critical role for RASSF1 heterodimerisation compared to 
RASSF5. Alternatively, the kinks introduced by the proline mutations could affect the secondary 
structure of SARAH as a whole. It has been shown that the MST1 binding interface increases due to 
these distortions28, so it is plausible that the introduction of proline into RASSF1-SARAH severely 
distorts its helical structure to the detriment of its ability to dimerise. This effect could be less severe 
in RASSF5, thus its mutants retain their ability to heterodimerise, albeit at a diminished level.  
We also investigated the differences in the binding characteristics between the isolated SARAH 
domain and the full length MST1 when interacting with those RASSF proteins that are able to 
dimerise (RASSF1-6). Figure 9A shows the plate map for this experiment. Initially we fitted the donor 
fluorescence data to a monoexponential decay model, as for the previous assays. The plate map of 
EGFP donor lifetimes averaged over 10 FOV are shown colour-coded in figure 9A together with box 
plots of the lifetimes on a per cell basis in figure 9B. It is immediately apparent that the EGFP 
lifetimes are more reduced when the RASSF proteins 1-6 interact with the isolated SARAHMST1 
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domain compared to when they dimerise with the full length MST1. This is observed for all RASSF1-
6, and is supported by the 2D plots of EGFP lifetimes vs. donor/acceptor ratios (figure 9D) even 
though the donor/acceptor ratios vary among the different conditions within the plate (figure 9C). 
These data could be explained by a larger mean donor-acceptor FRET distance for the interaction of 
full length MST1 with RASSF1-6 compared to the interaction with the isolated SARAH domain, e.g. 
due to steric constraints. This would reduce the FRET efficiency, due to its dependence to the sixth 
power of the donor-acceptor distance. Alternatively, the fraction of bound molecules, e.g. due to a 
different binding affinity of RASSF1-6, could be different for the two interactions. 
To understand more about the interactions producing the observed differences in the readout based 
on fitting to the monoexponential decay model, the data underlying figure 9 was fitted to a double 
exponential decay model (equation 2), using the global analysis capabilities of FLIMfit35. 
𝐼𝐼(𝑡𝑡) = 𝐼𝐼0 �(1 − β)𝑒𝑒− 𝑡𝑡τ𝐷𝐷 + β 𝑒𝑒− 𝑡𝑡τ𝐷𝐷𝐷𝐷  �        Eq. 2 
The two lifetime components contributing to the EGFP (donor) decay profiles arise from non-
interacting RASSF molecules (unquenched donor, τD) and from RASSF molecules that are bound 
either to the isolated SARAH domain or to the full length MST1 kinase (donor quenched by FRET, 
τDA). The unquenched donor lifetime was determined using data from the cells transfected only with 
RASSF1-6 and this component was fixed during the global fitting. The donor lifetime quenched by 
FRET was allowed to vary, but was constrained to be spatially invariant across all cells within a given 
experimental condition. Thus, the fraction of interacting molecules (β term in equation 2) could be 
estimated and these results are presented in the box plots shown in figure 10A (the full list of 
parameters obtained from this analysis are presented in the supplementary information). Owing to 
the challenges associated with quantifying FRET interactions between fluorescent proteins that are 
applicable to all such assays38, these absolute values show relatively broad distributions, but the 
results clearly indicate a lower fraction of bound molecules in the case of the RASSF interaction with 
the full length MST1 protein compared to the isolated SARAHMST1 domain. 
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To understand if the results in figure 10A are indeed due to a difference in binding affinities, we 
need to estimate the dissociation constants KD for the interactions of MST1 with the different 
RASSF1-6 proteins. For this we can use the binding population fractions from the global FLIM 
analysis, but it is also necessary to estimate the concentrations of the MST1 and RASSF1-6 proteins 
from the EGFP and mCherry fluorescence intensities. To this end we used the Nipkow disc unit to 
implement optically sectioned FLIM in order to constrain the detected emission to a well-defined 
focal volume. The instrument was calibrated using solutions of purified fluorescent EGFP and 
mCherry at known concentrations in phosphate buffer pH 7.4. Figure 10B,C shows the linear 
relationship between the average detected fluorescence intensity per pixel and the fluorophore 
concentration.  
Dissociation constants KD were calculated for each cell assuming a bi-molecular reaction (equation 
3), where D is the donor-labelled partner, A is the acceptor-labelled partner and DA is the complex 
formed by their association: 
𝐷𝐷𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 + 𝐴𝐴𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 ↔ 𝐷𝐷𝐴𝐴         Eq. 3 
KD is then given by equation 4, which relates the concentrations of the binding partners to the 
complex: 
𝐾𝐾𝐷𝐷 = �𝐷𝐷𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓��𝐴𝐴𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓�[𝐷𝐷𝐴𝐴]          Eq. 4 
Using the fluorophore concentration calibration we can determine the total donor (Dtotal) and 
acceptor (Atotal) concentrations per cell, while the FRET fraction β obtained from the global analysis 
provides an estimate of the concentration of the DA complex via the bound fraction of the donor.  
We can then write: [𝐷𝐷𝐴𝐴] = β 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡         Eq. 5 [𝐷𝐷𝐴𝐴] = γ 𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡         Eq. 6 
where γ is the bound fraction of the acceptor molecules within the complex. This fraction can be 
calculated from Eq. 5 and 6: 
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γ = β 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
          Eq. 7 
Knowing the bound D and A fractions, we can obtain the free fractions and re-write the KD 
expression: 
𝐾𝐾𝐷𝐷 = (1−β ) (1−β 𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷 )𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷β         Eq. 8 
where ID and IA are the fluorescence intensities of the donor and acceptor respectively, which are 
linearly proportional to the concentrations via the proportionality constants cD and cA (figure 10B,C). 
A full derivation of this equation is presented in the supplementary information. To estimate the 
donor (EGFP) concentration in the cells, the fitted initial intensity of the fluorescence decay (at t=0) 
was used rather than the total fluorescence intensity because the FRETing and non-FRETing donors 
have different brightness due to their different lifetimes and quantum yields. 
The KD values obtained for all the conditions in the plate are plotted in figure 10D and are in the 
same range as previously published values: C. Herrmann and colleagues39-41 determined a 
dissociation constant KD in the order of hundreds of nM for the RASSF5-MST1 complex in FRET 
experiments using stopped-flow fluorimetry, while the self-association constant for RASSF5 was 
found to be 5-10 µM, and that for MST1 was in the low nM range. In their case, KD was calculated as 
the ratio between the association rate constant kon and the dissociation rate constant koff. They 
measured a higher koff when full length RASSF5 dimerised with the isolated SARAH domain of MST1 
than in the case when dimerisation was performed between the isolated SARAH domains of the two 
proteins, indicating that the full length proteins have a lower affinity than the isolated dimerising 
domains. Although in our experiments the KD values for the isolated SARAH domain and the full 
length MST1 are not clearly separated (figure 10D), there appears to be a trend towards higher 
average KD values for the RASSF-full length MST1 interaction, suggesting it has a lower interaction 
strength than the MST1 interaction with the isolated SARAH domain. 
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Conclusions 
We have developed a high content assay utilising FLIM FRET to screen for binding partners of MST1 
kinase among the RASSF protein family and to quantify the relative interaction affinities. Our custom 
automated FLIM multiwell plate microscope based on time gated detection is capable of rapid 
automated image acquisition and therefore facilitates systematic studies of bimolecular processes to 
provide statistically robust readouts that quickly highlight any systematic errors and effectively 
average over biological variations. We note that the results presented here and in our previous 
work11, 35 highlight that the ability to apply global fitting over such large data sets enables us to take 
advantage of FRET assays with modest lifetime changes (100-200 ps).  
We have demonstrated how a relatively simple wide-field FLIM plate microscope can be applied 
with fitting to monoexponential decay models to provide robust qualitative readouts of FRET, 
enabling protein interactions to be identified. This is of practical significance since fitting to 
monoexponential decay models is much less sensitive to system errors such as variations in the 
instrument response function, compared to fitting to more complex models and there is a wide 
range of software tools available to fit FLIM data to a monoexponential decay models on a pixel-
wide basis. We also note the importance of plotting the ratio of acceptor to donor fluorescence 
intensities as a function of donor lifetime to elucidate the impact of relative concentrations, e.g. due 
to variations in transfection efficiency. For more quantitative measurements, the global fitting 
capabilities of software tools such as FLIMfit complement the capacity of the FLIM plate reader to 
acquire 100’s-1000’s of FOV and permit the population of FRETing donors to be estimated. We have 
shown that this can be extended to estimate the KD of protein interactions, which could be used to 
map systematically signalling networks, providing that the donor and acceptor fluorophore 
concentrations can be quantified and for this we implemented optical sectioning using a spinning 
Nipkow disc with our wide-field detection.  
The variation in expression levels enabled us to overcome the impossibility of varying the 
concentrations of the interacting partners within cells in a controlled manner, as usually done when 
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determining KD. By analysing a large number of cells resulting from segmenting hundreds of fields of 
view, it was possible to obtain data for a range of protein concentrations within a single experiment. 
We note that for the case of RASSF6, the statistics were less favourable due to relatively fewer cells 
surviving the transfection process - although the same conditions were applied as for the other 
RASSF proteins. Thus the data for RASSF6 should be interpreted with particular caution. 
The values obtained for the KD are in reasonable agreement with those obtained in previous 
experiments utilising different biochemical techniques and report that the binding affinity is lower in 
the case of heterodimerisation between RASSF proteins and full length MST1 kinase compared to 
the heterodimerisation of RASSFs with the isolated SARAH domain from MST1. Our experiments 
thus illustrate the potential to apply automated high content FLIM FRET assays to screen for binding 
partners and estimate KD values in cells, which should offer advantage in convenience and biological 
relevance compared to in vitro measurements using purified proteins. To our knowledge, automated 
FRET-based assays to determine KD have previously been applied only in solution, either by intensity 
measurements42-44 or by time-resolved measurements of europium luminescence45. Previous reports 
on KD determination using FRET in cells are limited to intensity-based FRET46,47, although there is one 
report of using FLIM to detect FRET and calculate the KD48, but these measurements were not 
implemented in an automated platform to screen protein-protein interactions. Fluorescence 
correlation spectroscopy has also been used to determine KD49,50.  
We believe that this automated FLIM FRET HCA approach provides a means to screen for protein 
interactions in their native context that could be scaled to screen large compound libraries. It could 
also be applied to map cell signalling networks. However, the quantiﬁcation of the strength of 
specific interactions does rely on key simplifying assumptions. Below we point out some limitations 
of the current implementation:  
i) The approach here using a simple donor/acceptor FRET pair is applicable to bimolecular 
interactions, including dimerisation, with a stoichiometry of 1:1. If more than two binding 
partners interact, e.g. to oligomerise or to form a complex, then FRET could take place between 
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multiple donors and acceptors. The analysis and fitting model would have to be adapted and 
potentially more complex labelling schemes should be considered, as well as more sophisticated 
readouts including time-resolved fluorescence anisotropy or parallel measurements of acceptor 
as well as donor fluorescence. While this would be challenging, we note that three- or four-colour 
FRET schemes have been implemented using single molecule measurements55,56 or 
confocal/multiphoton fluorescence microscopy57,58. These approaches have been used to study 
conformational changes in RNA and DNA, multiple protein interactions59,60 and oligomerisation61, 
although KD values have not been obtained from such studies. Our current technique could be 
extended to read out multiple bimolecular interactions within the same or different signalling 
pathways using multiplexed FRET probes, as we and others have previously shown62,63. 
ii) Our approach provides information on the interaction strength between the expressed 
fluorescently-labelled proteins but one has to consider that, depending on the cell type, the 
corresponding unlabelled endogenous proteins could also be interacting with the labelled 
proteins and this would impact the estimates of KD50. Most cell-signalling components are 
expressed at relatively low levels (e.g. compared with housekeeping proteins) and for the Cos7 
cells used here, we expect the concentration of the endogenous proteins to be 5-10x lower than 
the corresponding over-expressed labelled protein. Nevertheless, further controls could be 
implemented in future studies that could include performing experiments in knockout cell lines 
for proteins of interest or depleting endogenous proteins to verify that this has no effect on KD 
estimates. Another approach to overcome this problem would be to label the endogenous 
proteins using gene editing techniques such as CRISPR/Cas and assay their interactions.  
iii) Estimations of KD based on FRET measurements using fluorescent proteins as donor and acceptor 
fluorophores can be subject to artefacts owing to the uncertainty in the average κ2 dipole 
orientation factor that arise from the fact that the fluorophores do not dynamically randomise 
their relative orientations during the fluorescence decay38, since the rotational correlation time of 
fluorescent proteins is typically large compared to the excited state lifetime64. This can lead to 
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extended FRET efficiency probability distributions that could impact the estimation of the 
FRETing population fraction and therefore KD. Estimations of the FRETing population fraction can 
also be impacted by dark acceptor states38. These considerations impact all quantitative FRET 
measurements with fluorescent proteins yet such measurements are widely used and have 
provided a range of insights into biological processes. If these considerations can be addressed, 
e.g. by implementing FRET with smaller fluorophores that do result in dynamic averaging of 
dipole orientation, then the precision and reliability of KD estimation could be improved. 
iv) Our estimation of KD requires knowledge of the absolute concentration of donor and acceptor 
fluorophores, which we obtain by assuming that the quantum yield of the GFP and mCherry 
fluorescent proteins is the same in aqueous solution as it is in the cell and that it does not vary 
significantly throughout the cell. Previous measurements of EGFP report that it presents similar 
brightness in the cytoplasm and nucleus to what it presents in solution65. 
The automated FLIM FRET assays reported in this work were undertaken with fixed cells, but could 
readily be applied to live cells for which similar performance is expected, in line with our previous 
work51. We are developing an open hardware approach to FLIM high content analysis and the latest 
versions of our open source software for data acquisition and analysis, together with and 
descriptions of hardware components is available on our website at   
http://www3.imperial.ac.uk/photonics/research/biomedical-imaging/openflimhca. 
 
 
Materials and methods 
DNA constructs. Full length RASSF1-10 were cloned into the Gateway®-modified pEGFP-C1 vector 
(Clontech) to produce constructs with an N-terminus EGFP tag as described in ref. 15. MST1 
(residues 1-487), MST1ΔSARAH (residues 1-431) and MST1-SARAH (residues 432-487) were cloned 
into pmCherry-C1 vector (Clontech) by restriction digest and ligation at the BglII and HindIII sites. 
The pTriEx6-MST1 K59R kinase-dead mutant construct used in the biochemical studies has been 
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previously described in ref. 15. All RASSF5 constructs used in this study were derived from the 
RASSF5C isoform, which has an identical C-terminus region and SARAH domain to RASSF5A.  
Mutagenesis was performed using the QuickChange® Site-Directed Mutagenesis Kit (Stratagene) 
following the manufacturer’s instructions. All mutant constructs were sequence verified. 
Co-immunoprecipitation was performed using the Anti-c-Myc Immunoprecipitation kit (Sigma) using 
co-transfected cell lysates as described in ref. 15. All co-IP assays were repeated three times.  
Western blots. Antibodies used for identification are anti-GFP (B2) (Santa Cruz), anti-GAPDH (Santa 
Cruz), anti-myc (in-house). Bands from Western blotting were quantified using ImageJ. The relative 
intensity of the WT control was set at 1 for each experiment and used as a reference point. The error 
bars are the standard deviations, p-values were calculated using the Student’s t-test and indicated as 
follows: p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***). 
Protein modelling. Docking programs Hex (http://hexserver.loria.fr/index.php) and ClusPro 
(http://nrc.bu.edu/cluster) were used for rigid body docking and to run simulations of the 
heterodimers consisting of the monomer structures of MST1 (PDB: 2JO8) and the RASSF SARAH 
homology models from ref. 15. Each run generated 100 or more solutions that were ranked by 
cluster sizes and the top two ranked models were selected and analysed using naccess 
(http://www.bioinf.manchester.ac.uk/naccess/).  
Cells. COS7 cells (ECACC) were grown in DMEM supplemented with 10% fetal calf serum, 2 mM 
glutamine, 1 mM sodium pyruvate and 1% penicillin-streptomycin and were used for all 
experiments. All fluorescent constructs were transfected via electroporation. Typically, 1-1.5 x 106 
cells were suspended in 100 µl homemade electroporation buffer (140 mM KCl, 8 mM NaCl, 0.88 
mM MgSO4, 2.97 mM Na2HPO4, 1.06 mM NaH2PO4 and 0.5% (w/v) bovine serumalbumin (pH = 7.4), 
filtered through a 0.2 µm membrane for sterilisation). 4.5 µg of plasmids in different combinations 
(indicated in the figures) were added to this suspension. Electroporation was performed using an 
Amaxa NucleofectorTM II (Lonza, Switzerland) using the manufacturer’s program for COS7 cells. Cells 
were then seeded in a 96-well plate (Greiner Bio-One) at a density of 30 000 cells/well and fixed the 
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following day using 4% paraformaldehyde for 20 minutes at room temperature, washed 3 times in 
phosphate buffer saline (PBS) and imaged in PBS. 
Automated FLIM multiwell plate reader. The instrument shown in figure 2 was constructed around 
a motorised Olympus IX 81-Z microscope with ZDC autofocus. The pulsed excitation radiation (60 
MHz repetition rate) is selected from the output of a supercontinuum laser (SC 400-6, Fianium Ltd, 
UK) using band pass filters (Semrock) arranged in a motorised filter wheel. 
For wide-field imaging the excitation is directed via a single-mode optical fibre to the back 
illumination port of the microscope after passing through a rotating diffuser wheel and relayed to 
the focal plane of the microscope to realise Köhler illumination. The samples arrayed in a 96-well 
plate were mounted on a motorised x-y stage (Märzhäuser Wetzlar GmbH, Germany) and imaged 
using a 20x objective (Olympus UPlanFl 20x/0.5). Appropriate dichroic mirrors and emission filters in 
the motorised filter cube wheel (GFP: excitation 472/30 nm, dichroic 495 nm, emission 520/35 nm; 
mCherry: excitation 545/30 nm, dichroic 570 nm, emission 610/75 nm) provided automated 
selection of spectral channels. The emitted fluorescence light was imaged via the left-hand port of 
the microscope to a gated optical intensifier (GOI) (Kentech Instruments Ltd., UK) and the resulting 
gated images at the phosphorus screen were imaged to a cooled CCD camera (Orca ER II, 
Hamamatsu, Japan). The GOI gating voltage signal is synchronised and delayed with respect to the 
laser excitation pulses under computer control. For the work reported here, the GOI gate width was 
set to 1 ns and typically time-gated images of EGFP fluorescence were acquired at 5 different delays 
after excitation while only one time gated image (at the beginning of the decay) was acquired for the 
mCherry emission. The integration time of the CCD camera was set to 1-2 s per gate delay for EGFP 
and 5-6 s for the mCherry image acquisition such that the dynamic range of the CCD was utilised. 
For the optically sectioned FLIM acquisitions used to provide the data for the KD calculations, the 
instrument was configured to incorporate a spinning Nipkow disk unit (CSU-X1 Yokogawa Electric 
Corporation, Japan), as described in refs. 52-54, with a 40x air objective (Olympus, LUCPLFLN 40) 
with an NA of 0.6. The pulsed excitation was directed via a polarisation-preserving single mode 
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optical fibre to the input of the spinning Nipkow disk unit and the fluorescence image was relayed 
onto the GOI where the time-gated images were acquired as for the wide-field configuration. 
In addition to the time-gated FLIM FRET data, a FLIM acquisition of a scattering sample detected at 
the excitation wavelength was acquired to provide an instrument response function (IRF) for the 
data analysis. Time-gated FLIM was also applied to a well containing only PBS in order to determine 
the time varying background.  
FLIM data acquisition and analysis. The instrument is controlled using a programme written in 
LabVIEW (National Instruments, USA). This controls the automatic movement of the stage, the 
autofocusing of each field of view, the automatic change of the excitation filters, of the filters and 
dichroics in the filter cube wheel, the objective lens change, the GOI gating and the CCD camera 
acquisition. A “prefind” scan was implemented to image the well plate using fluorescence intensity 
to identify and localise cells and to acquire donor and acceptor intensity images. Specific fields of 
view in various wells were selected for subsequent FLIM after applying an intensity threshold. FLIM 
data analysis was performed using the custom written open source software, FLIMfit, described in 
detail in ref. 35 and freely available at www.openmicroscopy.org/site/products/partner/flimfit. For 
the work reported here we utilised the following capabilities of FLIMfit: cell segmentation based on 
donor and/or acceptor intensity; calculation of average fluorescence intensity of donor and acceptor 
per cell; fitting the donor fluorescence intensity decays to monoexponential and to double 
exponential decay models (including instrument response function (IRF) and time-varying 
background correction); global fitting of donor fluorescence intensity decays across multiple fields of 
view and wells; visualisation of FLIM data (including rendering of plate maps showing mean EGFP 
decay times per well and images of one field of view per well). To utilise the relatively small changes 
in donor lifetime that we have obtained in the FLIM FRET assays reported here from fits to double 
exponential decay models, it is critical to minimise fluctuations in the IRF and to account for any 
residual variation. This was realised by acquiring FLIM data of a reference dye solution (rhodamine 
6G) in some of the plate wells and fitting the measured decay data to a monoexponential model in 
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order to precisely determine the relative excitation time (i.e. the start of the decay profile, t0), for 
each plate. This information was combined with the measurement of a scattering sample to 
construct the IRF that is convolved with the exponential decay model to provide the function to 
which the experimental FLIM data is fitted. Graphs of lifetime and intensity ratio parameters were 
plotted in Origin 8 (OriginLab, USA).  
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FIGURE CAPTIONS 
 
Figure 1. Schematic of Ras-dependent pathways determining cell fate. 
Figure 2. Schematic representation of the fluorescent constructs used for the FRET assays. The 
domain structure of the RASSF family members, of their possible interacting partners (MST1 kinase and 
its isolated SARAHMST1 domain) and of the negative controls are shown. 
Figure 3. Schematic of automated plate reader based on time-gated fluorescence lifetime imaging 
(FLIM). A) The pulsed excitation light is selected with an appropriate filter from the “white light” 
emitted by an ultrafast supercontinuum laser source and enters the microscope either in a wide-field 
configuration or via a Nipkow disk unit to provide optical sectioning. The fluorescence is detected via 
a gated optical intensifier (GOI) that acts as a fast (∼100 ps rise time) electronic shutter synchronised 
with the laser pulses. The GOI opens at various delays after excitation (e.g. t1, t2, t3) and intensity 
images are acquired with a CCD camera at each time delay, integrating for a few seconds. B) Lifetime 
determination. The time-gated images (t1, t2, t3) are used to reconstruct the fluorescence decay of the 
fluorophore, which is analysed by fitting exponential decay functions, discriminating between the 
lifetime of the donor only (D only) and the lifetime of the donor undergoing FRET in the presence of the 
acceptor (D + A). 
Figure 4. Comparison of the RASSF family members in terms of dimerisation with the SARAHMST1 
domain using FRET. A) Plate map showing average EGFP donor lifetimes (ps) calculated for 10 fields 
of view (FOV) per well using a monoexponential fit. B) False-colour FLIM images of cells from a typical 
FOV in each well showing the EGFP lifetime (ps) per pixel. C) Box plots showing median EGFP lifetimes, 
interquartile (box range), standard deviation (whisker), 1% and 99% percentile (x) and minimum/maximum 
values (-) calculated for individual cells averaged over 10 FOV per well using monoexponential analysis: 
green: EGFP-RASSF(1-10) only; red: EGFP-RASSF(1-10) + mCherry-SARAHMST1; blue: EGFP-RASSF(1-10) 
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+ mCherry-MST1∆SARAH (see supplementary material for a table of differences in mean fluorescence 
lifetime). D) Acceptor/donor intensity ratios (ImCherry/IEGFP) averaged over each cell for all the conditions 
in the plate. The colour code is the same as in C). E) Scattered plots of EGFP lifetimes versus 
acceptor/donor intensity ratios (ImCherry/IEGFP) calculated for individual cells (with same colour code as 
for C). FLIM data were acquired with wide-field imaging. 
Figure 5. Effect of three different point mutations within the SARAH domain of RASSF1 on the 
dimerisation with the isolated SARAHMST1. A) Plate map showing the average EGFP lifetimes 
calculated for 10 fields of view per well when fitting to a monoexponential decay profile. The wild-type 
EGFP-RASSF1 assay shows that mCherry alone can serve as a negative control as well as the mCherry-
MST1∆SARAH. B) Box plots showing median EGFP lifetimes, interquartile (box range), standard 
deviation (whisker), 1% and 99% percentile (x) and minimum/maximum values (-) for segmented cells in 
different conditions within the plate: green: EGFP-RASSF1 (wild type and mutants) only; red: EGFP-
RASSF1 (wild type and mutants) + mCherry-SARAHMST1; blue: EGFP-RASSF1 (wild type and mutants) + 
mCherry (see supplementary material for a table of differences in mean fluorescence lifetime). C) 
Average acceptor/donor intensity ratios (ImCherry/IEGFP) for the segmented cells in different conditions 
within the plate (same colour code as in B). D) 2D plots of acceptor/donor intensity ratios versus EGFP 
lifetimes for the segmented cells in different conditions within the plate (same colour code as in B). 
FLIM data were acquired with wide-field imaging. 
Figure 6. The effect of three different point mutations within the SARAH domain of RASSF5C on the 
dimerisation with the isolated SARAHMST1. A) Plate map showing the average EGFP lifetimes 
calculated for 10 fields of view per well fitted to a monoexponential decay model. B) Box plots showing 
median EGFP lifetimes, interquartile (box range), standard deviation (whisker), 1% and 99% percentile 
(x) and minimum/maximum values (-) for the segmented cells in different conditions within the plate: green: 
EGFP-RASSF5C (wild type and mutants) only; red: EGFP-RASSF5C (wild type and mutants) + mCherry-
SARAHMST1; blue: EGFP-RASSF5C (wild type and mutants) + mCherry (see supplementary material for a 
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table of differences in mean fluorescence lifetime). C) Average intensity ratios acceptor/donor 
(ImCherry/IEGFP) for the segmented cells in different conditions within the plate (same colour code as in B). 
D) 2D plots of intensity ratios acceptor/donor versus EGFP lifetimes for the segmented cells in different 
conditions within the plate (same colour code as in B). FLIM data were acquired with wide-field 
imaging. 
Figure 7. Effects of mutations in the SARAHRASSF1 domain on dimerisation with full length MST1. A) 
The SARAH domain sequence of RASSF1. Main interacting non-polar (yellow), acidic (red) and basic 
(blue) residues are shown. The three positions in which mutations were introduced are marked by 
asterisks (*). B) (i) Co-immunoprecipitation assay to show heterodimerisation between myc-MST1 
K59R and wild-type (WT) EGFP-RASSF1 and its three mutants. The loading controls are shown below. 
(ii) Quantification of the bands in terms of relative intensity to the WT control (Mean ± SD. n = 3; *p < 
0.05, **p < 0.01, ***p < 0.001). C) Co-immunoprecipitation assay of the negative controls. A 
simultaneous negative control was performed using cell lysates containing only EGFP-RASSF1 or its 
mutants. The loading controls are shown below. 
Figure 8. Effects of mutations in the SARAHRASSF5 domain on dimerization with full length MST1. A) 
The SARAH domain sequence of RASSF5. Main interacting non-polar (yellow), acidic (red) and basic 
(blue) residues are shown. The three positions in which mutations were introduced are marked by 
asterisks (*). B) (i) Co-immunoprecipitation assay to show heterodimerisation between myc-MST1 
K59R and wild-type (WT) EGFP-RASSF5 and its three mutants. The loading controls are shown below. 
(ii) Quantification of the bands in terms of relative intensity to the WT control (Mean ± SD. n = 3; *p < 
0.05, **p < 0.01, ***p < 0.001). C) Co-immunoprecipitation assay of the negative controls. A 
simultaneous negative control was performed using cell lysates containing only EGFP-RASSF5 or its 
mutants. The loading controls are shown below. 
Figure 9. Comparison of the RASSF family members in terms of dimerisation with the isolated 
SARAHMST1 domain and the full length MST1 using FRET. A) Plate map showing average EGFP lifetimes 
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(ps) calculated for 10 fields of view per well by fitting to a monoexponential decay model. B) Box plots 
showing median EGFP lifetimes, interquartile (box range), standard deviation (whisker), 1% and 99% 
percentile (x) and minimum/maximum values (-) calculated for individual cells from 10 FOV per well; green: 
EGFP-RASSF(1-6) only; red: EGFP-RASSF(1-6) + mCherry-SARAHMST1; purple: EGFP-RASSF(1-6) + 
mCherry-MST1. C) Average acceptor/donor intensity ratios (ImCherry/IEGFP) for all the conditions in the 
plate with same colour code is the same as in C). D) 2D scatter plots of acceptor/donor intensity ratios 
(ImCherry/IEGFP) versus EGFP lifetime calculated for individual cells with same colour code as B). FLIM data 
were acquired with optical sectioning using Nipkow disc unit. 
Figure 10. Results of global fitting of the donor fluorescence decay data underlying figure 9 to a 
double exponential decay model. A) FRET population fractions for RASSF1-6 interacting with 
SARAHMST1 (red) and full length MST1 (purple). B),C) EGFP and mCherry calibration of intensity versus 
fluorophore concentration. D) Dissociation constants (KD) for RASSF1-6 interacting with SARAHMST1 
(red) and full length MST1 (purple). 
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SARAH domain contact interface/ interaction mode 
 
Figure S.1. Heterodimeric models of the SARAHMST1 and SARAHRASSF domains. A) Multiple sequence 
alignments of the Prosite predicted SARAH domain. The secondary structural elements are indicated as 
helix 1 (H1) and helix 2 (H2). Non-polar residues that are critical for the hydrophobic framework are marked 
with asterisks (*). Important residues involved in dimerisation are also highlighted according to their 
properties: non-polar (yellow), acidic (red) and basic (blue). B) The structure of the MST1 monomer is in  
purple and the RASSF monomer in cyan. Non-polar (yellow), acidic (red) and basic (blue) side chains of 
the residues involved in the heterodimeric interface are shown. 
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Table S.1 Interface sizes (in Å2) calculated using naccess for the best SARAH heterodimer model of each 
RASSF with MST1. 
 
MST1 
with: 
Total  Side chain  Main chain  Non-polar  Polar 
RASSF1 2844.6 2733.1 111.6 2350.6 494.1 
RASSF2 2933.6 2808.9 124.6 2426.5 507.1 
RASSF3 2767.7 2684.2 83.5 2235.5 532.2 
RASSF4 2843.2 2731.5 111.7 2296.2 547.1 
RASSF5 2820.9 2717.3 103.5 2278.6 542.2 
RASSF6 2988.4 2889.5 98.9 2502.1 486.3 
 
 
Double exponential analysis of the plate measured with the Nipkow disk configuration (sectioned) 
For the double exponential analysis, the donor lifetime in the absence of FRET (τD) is calculated by 
averaging the values of the EGFP lifetimes obtained in the wells containing the donor only, while the 
values of the donor in the presence of the acceptor (τDA) are obtained by global analysis after fixing the 
donor only lifetime. These values are listed in the table S.2. 
Based on the donor only lifetime τD and the lifetime of the donor in the presence of the acceptor τDA, the 
FRET efficiency EFRET can be calculated, from which the donor-acceptor distance r is typically estimated in 
FRET experiments given that the Förster radius R0 is known for the specific fluorophores pair: 
𝐸𝐸 = 1 − τ𝐷𝐷𝐷𝐷
τ𝐷𝐷
= � 𝑅𝑅0
𝑟𝑟+𝑅𝑅0
�
6
      Eq. S1 
The R0 estimation is generally done with the assumption that the orientation angles between the donor 
and acceptor molecules are randomly distributed. This is considered to be true in the case of small dye 
molecules that can undergo fast rotation on time scales shorter than the fluorescence lifetime. It has been 
recently demonstrated that in the case of fluorescent proteins this assumption cannot hold because their 
rotational correlation times (15-20 ns) are much longer that their fluorescence decay time (2-4 ns) (Vogel 
S.S., Nguyen T.A., van der Meer B.W., Blank P.S. The impact of heterogeneity and dark acceptor states on 
FRET: Implications for using fluorescent protein donors and acceptors. PLoS ONE 7, e49593, 2012). Thus, 
the fluorescent proteins are constrained to a given orientation during the FRET measurements, and the 
orientation factor (depending on the angle between the two dipoles) must be taken into account as well 
as the donor-acceptor distance when calculating EFRET. 
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As it is very difficult to measure experimentally the orientation factor, Vogel et al. (Vogel S.S., van der 
Meer B.W., Blank P.S. Estimating the distance separating fluorescent protein FRET pairs. Methods 66, 131-
138, 2013) proposed an empirical relation to determine r in the case of fluorescent proteins, and we have 
used this reference to obtain the values shown in table S.2. 
 
Table S.2. EGFP lifetimes obtained from double exponential analysis, FRET efficiencies EFRET and donor-
acceptor distances r for the RASSF-SARAHMST1 and RASSF-full length MST1 interactions. 
 SARAH MST1 
τD (ps) τDA (ps) EFRET r (nm) τD (ps) τDA (ps) EFRET r (nm) 
RASSF1 2632 781 0.703 3.8 2632 889 0.662 4.0 
RASSF2 2682 956 0.644 4.1 2682 1081 0.597 4.3 
RASSF3 2660 716 0.731 3.7 2660 505 0.810 3.2 
RASSF4 2690 865 0.678 3.9 2690 907 0.663 4.0 
RASSF5 2685 805 0.700 3.8 2685 694 0.741 3.6 
RASSF6 2688 688 0.744 3.6 2688 705 0.734 3.7 
 
 
Derivation of the equation for KD calculation 
Dissociation constants KD were calculated for a bi-molecular reaction as described by equation S1, where 
D is the donor-labelled binding partner, A is the acceptor-labelled binding partner and DA is the complex 
formed by their association: 
𝐷𝐷𝑓𝑓𝑟𝑟𝑓𝑓𝑓𝑓 + 𝐴𝐴𝑓𝑓𝑟𝑟𝑓𝑓𝑓𝑓 ↔ 𝐷𝐷𝐴𝐴      Eq. S1 
KD is then given by equation S2, which relates the concentrations of the binding partners to the complex. 
𝐾𝐾𝐷𝐷 = �𝐷𝐷𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓��𝐴𝐴𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓�[𝐷𝐷𝐴𝐴]       Eq. S2 
Using the fluorophore concentration calibration (figure 10B,C in the text of the paper), we can determine 
the total donor (Dtotal) and acceptor (Atotal) concentrations, while the FRET fraction β obtained from the 
5 
 
FLIM global analysis provides an estimate of the concentration of the DA complex via the bound fraction 
of the donor. 
We can then write: [𝐷𝐷𝐴𝐴] = β 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑙𝑙      Eq. S3 [𝐷𝐷𝐴𝐴] = γ 𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑙𝑙       Eq. S4 
where γ is the bound fraction of the acceptor molecules within the complex. From the equality of Eq. S3 
and S4, this fraction can be determined: 
γ = β 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
       Eq. S5 
Knowing the bound D and A fractions, we can obtain the free fractions: 
�𝐷𝐷𝑓𝑓𝑟𝑟𝑓𝑓𝑓𝑓� = (1 − β) 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑙𝑙     Eq. S6 
�𝐴𝐴𝑓𝑓𝑟𝑟𝑓𝑓𝑓𝑓� = (1 − γ) 𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑙𝑙 = �1 − β𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 �𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑙𝑙   Eq. S7 
Replacing Eq. S6 and S7 in the KD expression, we obtain: 
𝐾𝐾𝑑𝑑 = �𝐷𝐷𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓��𝐴𝐴𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓�[𝐷𝐷𝐴𝐴] = (1−β) 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡�1−β𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 �𝐴𝐴𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡β 𝐷𝐷𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 = (1−β ) (1−β 𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷 )𝑐𝑐𝐷𝐷𝐼𝐼𝐷𝐷β   Eq. S8 
where ID and IA are the initial fluorescence intensity of the donor and the acceptor respectively, which are 
linearly proportional to the donor and acceptor concentrations via the proportionality constants cD and cA 
(as shown in figure 10B,C in the text of the paper). 
 
 
 
 
Tables of changes in donor fluorescence lifetime 
Tables S.3-S.5 compare the difference in EGFP lifetime between RASSF proteins interacting with 
SARAHMST1 and the negative control (MST1∆SARAH or mCherry). 
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Table S.3. Differences in mean fluorescence lifetimes between RASSF1-10 interacting with SARAHMST1 
and the negative control (MST1∆SARAH) (same data as presented in figure 4 in the text of the paper). 
 Mean difference in EGFP 
lifetime (ps) 
RASSF1 233 
RASSF2 244 
RASSF3 279 
RASSF4 248 
RASSF5 314 
RASSF6 138 
RASSF7 25 
RASSF8 6 
RASSF9 12 
RASSF10 27 
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Table S.4. Mean lifetime differences between RASSF1 mutants interacting with SARAHMST1 and with the 
negative control (mCherry) (data presented in figure 5 in the text of the paper). 
 Mean difference of EGFP 
lifetime (ps) 
RASSF1 240 
RASSF1 L301P 2 
RASSF1 L305P 5 
RASSF1 L308P 17 
 
 
 
Table S.5. Mean lifetime differences between RASSF5 mutants interacting with SARAHMST1 and with the 
negative control (mCherry) (data presented in figure 6 in the text of the paper). 
 Mean difference of EGFP 
lifetime (ps) 
RASSF5 294 
RASSF5 L224P 201 
RASSF5 L228P 109 
RASSF5 L231P 165 
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Examples of dissociation constants KD for homo- and heterodimerisation of RASSF and MST proteins 
from literature data 
The following data have been taken from references 26 and 39-41, as numbered in the text of the paper. 
NORE1 is the alternative name for RASSF5. The numbers between brackets represent the aminoacid 
sequence that was used in the study. Point mutations (e.g. L444P) are also indicated. Abreviations: NMR = 
nuclear magnetic resonance, ITC = Isothermal titration calorimetry, SFF = stopped-flow fluorimetry, CD =  
circular dichroism, CPM = 7-diethylamino-3-(4’maleimidylphenyl)-4-methylcoumarin, FM = fluorescein-
5-maleimide, eCFP = enhanced cyan fluorescent protein, eYFP = enhanced yellow fluorescent protein. 
 
 
 
Table S.7. KD values for NORE1 (RASSF5) and MST1 homo- and heterodimerisation published in 
literature. 
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Protein1 Protein2 KD (µM) Method Ref. 
RASSF5 SARAH 
(366-413) 
MST1 SARAH 
(432-480) 
Low nM range NMR 26 
NORE1 SARAH 
(369-413) 
NORE1 SARAH 
(369-413) 
34.4 ± 16.4 (at 25°C) 
154.5 ± 20.5 (at 30°C) 
ITC 39 
MST1 Inhibitory+SARAH 
(330-487) L444P 
MST1 Inhibitory+SARAH 
(330-487) L444P 
34.1 ± 4.6 (at 25°C) ITC 39 
NORE1 RBD+SARAH 
(199-413) C220S/R242C-CPM 
NORE1 RBD+SARAH (199-
413) C220S/R242C-FM 
3.8 FRET in SFF 39 
NORE1 RBD+SARAH 
(199-413) C220S/R242C-CPM 
NORE1 RBD+SARAH 
(199-413) C220S/C414-FM 
4.7 FRET in SFF 39 
NORE1 RBD+SARAH 
(199-413) C220S/C414-CPM 
NORE1 RBD+SARAH 
(199-413) C220S/C414-FM 
9.8 FRET in SFF 39 
NORE1 RBD+SARAH 
(199-413) C220S/R242C-CPM 
NORE1 SARAH 
(369-413) C220S/C414-eYFP 
3.1 FRET in SFF 39 
NORE1 RBD+SARAH 
(199-413) C220S/C414-CPM 
NORE1 SARAH  
(369-413) C220S/C414-eYFP 
8.3 FRET in SFF 39 
MST1 Inhibitory+SARAH 
(330-487) F487C-CPM 
MST1 SARAH 
(437-487)-eYFP 
Low nM range FRET in SFF 39 
MST1 Inhibitory+SARAH 
(330-487) E460C-CPM 
MST1 Inhibitory+SARAH 
(330-487) E460C-FM 
Low nM range FRET in SFF 39 
NORE1 SARAH 
(369-413)-eCFP 
MST1 SARAH 
(437-487)-eYFP 
0.2 FRET in SFF 39 
NORE1 SARAH 
(369-413)-eCFP 
MST1 Inhibitory+SARAH 
(330-487)-eYFP 
0.6 FRET in SFF 39 
NORE1 RBD+SARAH 
(199-413) C220S/C414-CPM 
MST1 SARAH 
(437-487)-eYFP 
0.7 FRET in SFF 39 
NORE1 SARAH 
(369-413)-eCFP 
MST1 SARAH 
(437-487) L444P-eYFP 
0.6 FRET in SFF 39 
MST1 SARAH 
(437-487) 
MST1 SARAH 
(437-487) 
1.07 ± 0.7 CD 40 
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MST1 SARAH 
(437-487) 
MST1 SARAH 
(437-487) 
0.9 ± 0.1 ITC 40 
NORE1 SARAH 
(370-413) 
NORE1 SARAH 
(370-413) 
28 CD 41 
 
